Cargando…
Adjuvant interferon alpha 2b in high risk melanoma – the Scottish study
In 1989, the Scottish melanoma group initiated a randomized trial, comparing observation alone with 6 months' therapy with low dose interferon α (given subcutaneously 3 MU day(–1), thrice weekly), for patients with primary melanomas of at least 3 mm Breslow thickness, or with evidence of region...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363881/ https://www.ncbi.nlm.nih.gov/pubmed/11379605 http://dx.doi.org/10.1054/bjoc.2000.1623 |